Delivery Order SPE2DE24D0021-SPE2D625F3CLJ
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,445.75 on August 21, 2025, by the Medical Supply Chain, a defense-oriented federal agency. The contract, which uses fixed price with economic price adjustment pricing, covers the supply of National Influenza/Respiratory Syncytial Virus/COVID-19 positive control materials in 6x0.5mL format for research use only (RUO). This is a child contract with no set-aside designation, indicating open competition procurement....
- Fisher Scientific Company L.L.C. was awarded a delivery order contract valued at $2,934.90 on September 3, 2025, by the Defense Department's Medical Supply Chain division for the procurement of National Flu/RSV/COVID positive test kits in 6x 0.5mL Reagent Use Only (RUO) format. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and has an ultimate completion date of September 10, 2025. Performance will take place in Pittsburgh, Pennsylvania. This...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,509.10 on August 12, 2025, for the supply of National Flu/Respiratory Syncytial Virus/COVID-19 positive control materials in 6x0.5 milliliter format designated for research use only (RUO). This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 19, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded without a set-aside designation,...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $1,467.45 from the Medical Supply Chain, a defense-oriented federal agency, for the procurement of National Flu/RSV/COVID positive test kits (6x0.5mL, research use only). The contract, awarded on July 28, 2025, with an ultimate completion date of August 4, 2025, represents a child contract under a larger vehicle and will be performed in Pittsburgh, PA. This award reflects Fisher Scientific's established role as a...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $1,477.33 from the Defense Medical Supply Chain for National Influenza/Respiratory Syncytial Virus/COVID-19 positive control specimens in 6x 0.5 milliliter format for research use only. Awarded on June 5, 2025, with an ultimate completion date of June 12, 2025, this contract carries no set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurements. The order will be fulfilled...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,925.00 for antigen COVID-19 testing kits under a contract with the Medical Supply Chain, a defense-affiliated federal agency. The award was issued on September 8, 2025, with an ultimate completion date of September 15, 2025. The contract utilizes fixed-price pricing with economic price adjustment and will be performed in Pittsburgh, Pennsylvania. This is a child contract with no set-aside designation, indicating it...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 20, 2025, for the procurement of National Flu/RSV/COVID positive test kits in 6x0.5ml configurations for research use only (RUO). This fixed-price delivery order with economic price adjustment carries a ceiling value of $1,327.00 and is set to be completed by August 27, 2025. The contract will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania, and was awarded by the Defense-focused Medical Supply Chain...
- This federal contract award, worth $1,759.56, was issued by the Medical Supply Chain division of the Department of Defense to Fisher Scientific Company L.L.C., doing business as Fisher Scientific. The contract is for the delivery of 4564506093 - NAT FLU/RSV/COV POS 6X.5ML RUO, which are likely diagnostic testing kits or reagents. The contract is a fixed-price with economic price adjustment delivery order and does not utilize any set-aside designations. Fisher Scientific is a major supplier of...
- This federal contract award, valued at $1,816.00, was issued by the Medical Supply Chain division of the Department of Defense to Fisher Scientific Company L.L.C. The contract is a fixed-price delivery order with economic price adjustment, and does not utilize a set-aside designation. The contract is for the delivery of 4565832718 - NAT FLU/RSV/COV POS 6X.5ML RUO, which are laboratory testing supplies and equipment. Fisher Scientific is a major supplier of scientific products, equipment, and...
- This is a federal contract award to Fisher Scientific Company L.L.C., doing business as Fisher Scientific, a for-profit limited liability company and major supplier of scientific products and services to federal agencies. The $1,816.00 fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) for 4567564186 National Flu/RSV/COVID-19 Positive Test Kits (6 x 0.5 mL) for Research Use Only (RUO). The contract has an ultimate completion date of March 20, 2025. Fisher...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3CLJDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,137.88 on September 10, 2025, by the Medical Supply Chain division of the Department of Defense to supply National Flu/RSV/COVID positive controls in 6x0.5ml format for research use only (RUO). This is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of September 17, 2025. The contract will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was not designated with any set-aside category, indicating competitive procurement. Fisher Scientific, a major federal supplier of scientific products, equipment, and laboratory supplies registered in SAM.gov since 2001, regularly provides specialized testing solutions and medical equipment to defense and civilian agencies, including the National Institutes of Health, Department of Veterans Affairs, and Food and Drug Administration. The company holds significant blanket purchase agreements with multiple federal agencies, including a $1.65 million toxicology and drugs of abuse reagents BPA with the Department of Veterans Affairs running through 2030, demonstrating its established capability in supplying specialized diagnostic and testing reagents to federal healthcare and research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/10/25 |